InterventionsHumans

Prescribing Trends and Comparative Risk of Type 2 Diabetes Progression in Prediabetes by Antihyperglycemic Drug Class

ADA Scientific Sessions 2026 Abstract

The paper

SIEW GM, ASTAVANS A, MATHIOUDAKIS N

ADA Scientific Sessions 2026 Abstract · 6 Jun 2026

Presented at ADA Scientific Sessions 2026 · Oral 1164-OR

doi.org/10.2337/db26-1164-or

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
Diabetes, Obesity & Metabolism · 4 Oct 2026